Letinib Capsules 4mg

Product Description

Product Name: Letinib Capsules 4mg

Product Form: Capsules

Pack Size: 30's

Manufactured By: 

Used For:

1. Thyroid cancer: Used for treating advanced or metastatic differentiated thyroid cancer in patients who are not candidates for radioactive iodine therapy.
2. Hepatocellular carcinoma (liver cancer): Used in combination with another drug (everolimus) for treating advanced liver cancer.
3. Renal cell carcinoma (kidney cancer): Used in combination with pembrolizumab for treating advanced kidney cancer.
4. Endometrial carcinoma: Used in combination with pembrolizumab for advanced endometrial cancer.

Side Effects:

Lenvatinib can cause various side effects, ranging from mild to severe. Common side effects include:

• Fatigue
• Diarrhea
• Decreased appetite
• Nausea and vomiting
• High blood pressure (hypertension)
• Weight loss
• Mouth sores
• Abnormal liver function tests

Serious side effects include:

• Heart problems (e.g., heart failure, arrhythmias)
• Severe bleeding
• Protein in the urine (proteinuria)
• Risk of infection (due to weakened immune system)
• Gastrointestinal perforation (hole in the stomach or intestines)

Precautions:

• Pregnancy: Lenvatinib can harm an unborn baby. It should not be used during pregnancy unless clearly needed, and effective contraception is recommended during treatment.
• Liver and kidney issues: Patients with pre-existing liver or kidney conditions may need dosage adjustments and careful monitoring.
• Hypertension: Regular monitoring of blood pressure is necessary, as Lenvatinib can cause or worsen high blood pressure.
• Heart conditions: Inform your doctor if you have a history of heart disease or high blood pressure.
• Proteinuria: Lenvatinib may cause protein in the urine, so kidney function should be monitored.
• Bleeding risk: Patients with a history of bleeding disorders or those taking blood thinners should be monitored closely.